Literature DB >> 15647444

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus.

I E A Hoffman, I Peene, L Cebecauer, D Isenberg, T W J Huizinga, A Union, L Meheus, K De Bosschere, F Hulstaert, E M Veys, F De Keyser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15647444      PMCID： PMC1755357          DOI： 10.1136/ard.2004.022111

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.

Authors:  Sahar A Elsayed; Mohamed A Esmail; Randa M Ali; Omar M Mohafez
Journal:  Clin Rheumatol       Date:  2019-06-03       Impact factor: 2.980

2.  Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus.

Authors:  Li Long; Yanying Liu; Shiyao Wang; Yi Zhao; Jianping Guo; Ping Yu; Zhanguo Li
Journal:  J Clin Immunol       Date:  2010-06-30       Impact factor: 8.317

3.  Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

Authors:  A Vannini; K Cheung; M Fusconi; J Stammen-Vogelzangs; J P H Drenth; A C Dall'Aglio; F B Bianchi; L E Bakker-Jonges; W J van Venrooij; G J M Pruijn; A J W Zendman
Journal:  Ann Rheum Dis       Date:  2006-09-19       Impact factor: 19.103

4.  Psoriasis in systemic lupus erythematosus: a single-center experience.

Authors:  Konstantinos Tselios; Kristy Su-Ying Yap; Rattapol Pakchotanon; Ari Polachek; Jiandong Su; Murray B Urowitz; Dafna D Gladman
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

5.  Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.

Authors:  B Vander Cruyssen; I E A Hoffman; H Zmierczak; M Van den Berghe; E Kruithof; L De Rycke; H Mielants; E M Veys; D Baeten; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

Review 6.  The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis.

Authors:  Cristiano Alessandri; Roberta Priori; Mariagrazia Modesti; Riccardo Mancini; Guido Valesini
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

7.  Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality.

Authors:  Murat Icen; Paulo J Nicola; Hilal Maradit-Kremers; Cynthia S Crowson; Terry M Therneau; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

8.  A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis.

Authors:  Peter Taylor; Juliane Gartemann; Jeanie Hsieh; James Creeden
Journal:  Autoimmune Dis       Date:  2011-09-11

9.  Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.

Authors:  Luis M Amezcua-Guerra; Rashidi Springall; Ricardo Marquez-Velasco; Lorena Gómez-García; Angélica Vargas; Rafael Bojalil
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease?

Authors:  Rokhsareh Meamar; Gholamreza Askari; Majid Ghasemi; Mohammad Reza Aghaye Ghazvini; Sahar Vesal; Mostafa Sharifkhah; Nazanin Alaei Faradonbeh; Leila Dehghani
Journal:  Int J Prev Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.